Mouse model to study human A β₂M amyloidosis: generation of a transgenic mouse with excessive expression of human β₂-microglobulin

References

• Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, et al A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin. Biochem Biophys Res Commun 1985;129:701–706.
   PubMed Web of Science ®Google Scholar
• Gorevic PD, Casey TT, Stone WJ, DiRaimondo CR, Prelli FC, Frangione B. β-2 microglobulin is an amyloidogenic protein in man. J Clin Invest 1985;76:2425–2429.
   PubMed Web of Science ®Google Scholar
• Gejyo F, Homma N, Suzuki Y, Arakawa M. Serum levels of β2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med 1986;314:585–586.
   PubMed Web of Science ®Google Scholar
• Floege J, Ehlerding G. β-2-microglobulin-associated amyloidosis. Nephron 1996;72:9–26.
   PubMedGoogle Scholar
• Yamamoto S, Gejyo F. Historical background and clinical treatment of dialysis-related amyloidosis. Biochim Biophys Acta 2005;1753:4–10.
   PubMedGoogle Scholar
• Jadoul M, Garbar C, Vanholder R, Sennesael J, Michel C, Robert A, Noël H, van Ypersele de Strihou C. Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients. Kidney Int 1997;51:1928–1932.
   PubMed Web of Science ®Google Scholar
• Kiss E, Keusch G, Zanetti M, Jung T, Schwarz A, Schocke M, Jaschke W, Czermak BV. Dialysis-related amyloidosis revisited. Am J Roentgenol 2005;185:1460–1467.
   PubMed Web of Science ®Google Scholar
• Chanard J, Bindi P, Lavaud S, Toupance O, Maheut H, Lacour F. Carpal tunnel syndrome and type of dialysis membrane. Br Med J 1989;298:867–868.
   PubMed Web of Science ®Google Scholar
• Gejyo F, Narita I. Current clinical and pathogenetic understanding of β2m amyloidosis in long-term haemodialysis patients. Nephrology (Carlton) 2003;8:S45–S49.
   Google Scholar
• Hou FF, Chertow GM, Kay J, Boyce J, Lazarus JM, Braatz JA, Owen WF Jr. Interaction between β2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis. Kidney Int 1997;51:1514–1519.
   PubMed Web of Science ®Google Scholar
• Yamaguchi I, Hasegawa K, Naiki H, Mitsu T, Matuo Y, Gejyo F. Extension of Aβ2M amyloid fibrils with recombinant human β2-microglobulin. Amyloid 2001;8:30–40.
   PubMed Web of Science ®Google Scholar
• Chatani E, Naiki H, Goto Y. Seeding-dependent propagation and maturation of β2-microglobulin amyloid fibrils under high pressure. J Mol Biol 2006;359:1086–1096.
   PubMed Web of Science ®Google Scholar
• Xue WF, Homans SW, Radford SE. Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc Natl Acad Sci USA 2008;105:8926–8931.
   PubMed Web of Science ®Google Scholar
• Naiki H, Yamamoto S, Hasegawa K, Yamaguchi I, Goto Y, Gejyo F. Molecular interactions in the formation and deposition of β2-microglobulin-related amyloid fibrils. Amyloid 2005;12:15–25.
   PubMed Web of Science ®Google Scholar
• Relini A, De Stefano S, Torrassa S, Cavalleri O, Rolandi R, Gliozzi A, Giorgetti S, Raimondi S, Marchese L, Verga L, et al Heparin strongly enhances the formation of β2-microglobulin amyloid fibrils in the presence of type I collagen. J Biol Chem 2008;283:4912–420.
   PubMed Web of Science ®Google Scholar
• Ivanova MI, Sawaya MR, Gingery M, Attinger A, Eisenberg D. An amyloid-forming segment of β2-microglobulin suggests a molecular model for the fibril. Proc Natl Acad Sci USA 2004;101:10584–10589.
   PubMed Web of Science ®Google Scholar
• Higuchi K, Yonezu T, Kogishi K, Matsumura A, Takeshita S, Higuchi K, Kohno A, Matsushita M, Hosokawa M, Takeda T. Purification and characterization of a senile amyloid-related antigenic substance (apoSASSAM) from mouse serum. apoSASSAM is an apoA-II apolipoprotein of mouse high density lipoproteins. J Biol Chem 1986;261:12834–12840.
   PubMed Web of Science ®Google Scholar
• Xing Y, Nakamura A, Korenaga T, Guo Z, Yao J, Fu X, Matsushita T, Kogishi K, Hosokawa M, Kametani F, et al Induction of protein conformational change in mouse senile amyloidosis. J Biol Chem 2002;277:33164–33169.
   PubMedGoogle Scholar
• Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991;108:193–199.
   PubMed Web of Science ®Google Scholar
• Schagger H, Jagow GV. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987;166:368–379.
   PubMed Web of Science ®Google Scholar
• Yan J, Fujii K, Yao J, Kishida H, Hosoe K, Sawashita J, Takeda T, Mori M, Higuchi K. Reduced coenzyme Q10 supplementation decelerates senescence in SAMP1 mice. Exp Gerontol 2006;41:130–140.
   PubMedGoogle Scholar
• Hoshino M, Katou H, Hagihara Y, Hasegawa K, Naiki H, Goto Y. Mapping the core of the β2-microglobulin amyloid fibril by H/D exchange. Nat Struct Biol 2002;9:332–336.
   PubMedGoogle Scholar
• Chiba T, Hagihara Y, Higurashi T, Hasegawa K, Naiki H, Goto Y. Amyloid fibril formation in the context of full-length protein: effects of proline mutations on the amyloid fibril formation of β2-microglobulin. J Biol Chem 2003;278:47016–47024.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Hasegawa K, Yamaguchi I, Tsutsumi S, Kardos J, Goto Y, Gejyo F, Naiki H. Low concentrations of sodium dodecyl sulfate induce the extension of β2-microglobulin-related amyloid fibrils at a neutral pH. Biochemistry 2004;43:11075–11082.
   PubMed Web of Science ®Google Scholar
• Zhang H, Sawashita J, Fu X, Korenaga T, Yan J, Mori M, Higuchi K. Transmissibility of mouse AApoAII amyloid fibrils: inactivation by physical and chemical methods. FASEB J 2006;20:1012–1014.
   PubMed Web of Science ®Google Scholar
• Pras M, Zucker-Franklin D, Rimon A, Franklin EC. Physical, chemical, and ultrastructural studies of water-soluble human amyloid fibrils. Comparative analyses of nine amyloid preparations. J Exp Med 1969;130:777–796.
   PubMed Web of Science ®Google Scholar
• Ge F, Yao J, Fu X, Guo Z, Yan J, Zhang B, Zhang H, Tomozawa H, Miyazaki J, Sawashita J, et al Amyloidosis in transgenic mice expressing murine amyloidogenic apolipoprotein A-II (Apoa2c). Lab Invest 2007;87:633–643.
   PubMedGoogle Scholar
• Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962; 10:355–364.
   Web of Science ®Google Scholar
• Higuchi K, Matsumura A, Honma A, Takeshita S, Hashimoto K, Hosokawa M, Yasuhira K, Takeda T. Systemic senile amyloid in senescence-accelerated mice. A unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab Invest 1983;48:231–240.
   PubMedGoogle Scholar
• Yamaguchi K, Takahashi S, Kawai T, Naiki H, Goto Y. Seeding-dependent propagation and maturation of amyloid fibril conformation. J Mol Biol 2005;352:952–960.
   PubMed Web of Science ®Google Scholar
• Davison AM. β2-microglobulin and amyloidosis: who is at risk? Nephrol Dial Transplant 1995;10(Suppl 10):S48–S51.
   PubMedGoogle Scholar
• Yang MC, Blutreich A, Das K. Nodular pulmonary amyloidosis with an unusual protein composition diagnosed by fine-needle aspiration biopsy: a case report. Diagn Cytopathol 2009;37:286–289.
   PubMedGoogle Scholar
• Fujimoto N, Yajima M, Ohnishi Y, Tajima S, Ishibashi A, Hata Y, Enomoto U, Konohana I, Wachi H, Seyama Y. Advanced glycation end product-modified β2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis. J Invest Dermatol. 2002;118:479–484.
   PubMed Web of Science ®Google Scholar
• Bellotti V, Chiti F. Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. Curr Opin Struct Biol 2008;18:771–779.
   PubMed Web of Science ®Google Scholar
• Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R. β2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 1990;344:742–746.
   PubMed Web of Science ®Google Scholar
• Benoit LA, Tan R. Xenogeneic beta 2-microglobulin substitution affects functional binding of MHC class I molecules by CD8+ T cells. J Immunol. 2007;179:3588–3595.
   PubMedGoogle Scholar
• Sousa MM, Cardoso I, Fernandes R, Guimarães A, Saraiva MJ. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am J Pathol 2001;159:1993–2000.
   PubMed Web of Science ®Google Scholar
• Ueda M, Ando Y, Hakamata Y, Nakamura M, Yamashita T, Obayashi K, Himeno S, Inoue S, Sato Y, Kaneko T, et al A transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR metabolisms. Biochem Biophys Res Commun 2007;352:299–304.
   PubMedGoogle Scholar
• Lundmark K, Westermark GT, Nyström S, Murphy CL, Solomon A, Westermark P. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci USA 2002;99:6979–6984.
   PubMed Web of Science ®Google Scholar
• Xing Y, Nakamura A, Chiba T, Kogishi K, Matsushita T, Li F, Guo Z, Hosokawa M, Mori M, Higuchi K. Transmission of mouse senile amyloidosis. Lab Invest 2001;81:493–499.
   PubMed Web of Science ®Google Scholar
• Kihara M, Chatani E, Sakai M, Hasegawa K, Naiki H, Goto Y. Seeding-dependent maturation of β2-microglobulin amyloid fibrils at neutral pH. J Biol Chem 2005;280:12012–12018.
   PubMed Web of Science ®Google Scholar
• Sasahara K, Yagi H, Sakai M, Naiki H, Goto Y. Amyloid nucleation triggered by agitation of β2-microglobulin under acidic and neutral pH conditions. Biochemistry 2008;47:2650–2660.
   PubMed Web of Science ®Google Scholar
• Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, Prusiner SB. Synthetic mammalian prions. Science 2004;305:673–676.
   PubMed Web of Science ®Google Scholar
• Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 2007;104:9741–9746.
   PubMed Web of Science ®Google Scholar
• Higuchi K, Kitagawa K, Naiki H, Hanada K, Hosokawa M, Takeda T. Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis. Biochem J 1991;279:427–433.
   PubMedGoogle Scholar
• Korenaga T, Fu X, Xing Y, Matsusita T, Kuramoto K, Syumiya S, Hasegawa K, Naiki H, Ueno M, Ishihara T, et al Tissue distribution, biochemical properties, and transmission of mouse type A AApoAII amyloid fibrils. Am J Pathol 2004;164:1597–1606.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Kasai R, Yamamuro T, Hosokawa M, Takeshita S, Takeda T. Amyloid deposition in the articular structures of AKR senescent mice. Arthritis Rheum 1981;24:1540–1543.
   PubMedGoogle Scholar
• Shimizu K, Higuchi K, Matsushita M, Yamamuro T, Takeda T. Immunohistochemical studies of age-associated amyloid deposition in the joint of senescence-accelerated mouse (SAM). Z Rheumatol 1992;51:243–248.
   PubMed Web of Science ®Google Scholar
• Krimpenfort P, Rudenko G, Hochstenbach F, Guessow D, Berns A, Ploegh H. Crosses of two independently derived transgenic mice demonstrate functional complementation of the genes encoding heavy (HLA-B27) and light (β2-microglobulin) chains of HLA class I antigens. EMBO J 1987;6:1673–1686.
   PubMedGoogle Scholar
• Khare SD, Hansen J, Luthra HS, David CS. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human β2-microglobulin (β2m) double transgenic mice with disrupted mouse β2m. J Clin Invest 1996;98:2746–2755.
   PubMed Web of Science ®Google Scholar
• Fukunishi S, Yoh K, Kamae S, Yoshiya S. β2-microglobulin amyloid deposit in HLA-B27 transgenic rats. Mod Rheumatol 2007;17:380–384.
   PubMedGoogle Scholar
• Relini A, Canale C, De Stefano S, Rolandi R, Giorgetti S, Stoppini M, Rossi A, Fogolari F, Corazza A, Esposito G, et al Collagen plays an active role in the aggregation of β2-microglobulin under physiopathological conditions of dialysis-related amyloidosis. J Biol Chem 2006;281:16521–16529.
   PubMed Web of Science ®Google Scholar
• Brancaccio D, Gallieni M, Niwa T, Braidotti P, Coggi G. Ultrastructural localization of advanced glycation end products and β2-microglobulin in dialysis amyloidosis. J Nephrol 2000;13:129–136.
   PubMed Web of Science ®Google Scholar
• Ancsin JB. Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit. Amyloid 2003;10:67–79.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Yamaguchi I, Hasegawa K, Tsutsumi S, Goto Y, Gejyo F, Naiki H. Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. J Am Soc Nephrol 2004;15:126–133.
   PubMed Web of Science ®Google Scholar
• Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, et al Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 1995, 373:523–527.
   PubMed Web of Science ®Google Scholar
• Yi S, Takahashi K, Naito M, Tashiro F, Wakasugi S, Maeda S, Shimada K, Yamamura K, Araki S. Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I. Am J Pathol. 1991; 138:403–412.
   PubMed Web of Science ®Google Scholar
• Teng MH, Yin JY, Vidal R, Ghiso J, Kumar A, Rabenou R, Shah A, Jacobson DR, Tagoe C, Gallo G, Buxbaum J. Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis. Lab Invest. 2001; 81:385–396.
   PubMed Web of Science ®Google Scholar
• Weissmann C, Flechsig E. PrP knock-out and PrP transgenic mice in prion research. Br Med Bull. 2003; 66:43–60.
   PubMed Web of Science ®Google Scholar